Based on previous research, we speculate that under the inflammatory conditions of UC, MAP3K2-mediated IL-18-dependent Th1 cell differentiation significantly promotes local intestinal inflammatory responses, while miR-340-5p, through its targeted inhibition of MAP3K2, effectively blocks this immune differentiation pathway, thereby alleviating colonic inflammation. This evidence concerns the gene IL18 and colitis.